LUMIBIRD shares have recently benefited from a buyers' comeback, which was accompanied by a rise in volumes and volatility. This situation suggests a continuation of the upward dynamic. Investors have an opportunity to buy the stock and target the € 14.8.
Summary
For a short-term investment strategy, the company has poor fundamentals.
Strengths
The prospective high growth for the next fiscal years is among the main assets of the company
The group usually releases upbeat results with huge surprise rates.
Weaknesses
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 54 times its estimated earnings per share for the ongoing year.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
Disclaimer:
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
